3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Buy
55
MOH Quote, Financials, Valuation and Earnings
Last price:
$330.05
Seasonality move
:
8.5%
Day range:
$320.21 - $331.02
52-week range:
$262.32 - $409.07
Dividend yield:
0%
P/E ratio:
16.12x
P/S ratio:
0.47x
P/B ratio:
4.07x
Volume:
519K
Avg. volume:
810.5K
1-year change:
-19.82%
Market cap:
$18.3B
Revenue:
$40.7B
EPS (TTM):
$20.43
Analysts' Opinion
-
Consensus RatingMolina Healthcare has received a consensus rating of Hold. The company's average rating is a Hold based on 6 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $338.38, Molina Healthcare has an estimated upside of 2.73% from its current price of $329.39.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $279.00 representing 100% downside risk from its current price of $329.39.
Fair Value
-
According to the consensus of 13 analysts, Molina Healthcare has 2.73% upside to fair value with a price target of $338.38 per share.
MOH vs. S&P 500
-
Over the past 5 trading days, Molina Healthcare has overperformed the S&P 500 by 7.24% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Molina Healthcare does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Molina Healthcare has grown year-over-year revenues for 20 quarters straight. In the most recent quarter Molina Healthcare reported revenues of $10.5B.
Earnings Growth
-
Molina Healthcare has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Molina Healthcare reported earnings per share of $4.44.
Enterprise value:
12.2B
EV / Invested capital:
--
Price / LTM sales:
0.47x
EV / EBIT:
7.16x
EV / Revenue:
0.30x
PEG ratio (5yr expected):
1.84x
EV / Free cash flow:
22.46x
Price / Operating cash flow:
34.92x
Enterprise value / EBITDA:
6.45x
Gross Profit (TTM):
$4.7B
Return On Assets:
7.66%
Net Income Margin (TTM):
2.9%
Return On Equity:
25.84%
Return On Invested Capital:
17.03%
Operating Margin:
3.62%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $32B | $34.1B | $40.7B | $9B | $10.5B | |
| Gross Profit | $3.9B | $4.3B | $4.7B | $1B | $1.1B | |
| Operating Income | $1.4B | $1.6B | $1.7B | $316M | $380M | |
| EBITDA | $1.3B | $1.7B | $1.9B | $359M | $428M | |
| Diluted EPS | $13.55 | $18.78 | $20.43 | $3.70 | $4.44 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.9B | $10.1B | $10.1B | $12.5B | $12.8B | |
| Total Assets | $9.5B | $12.2B | $12.3B | $14.9B | $15.6B | |
| Current Liabilities | $5B | $7B | $6.9B | $8.2B | $7.9B | |
| Total Liabilities | $7.4B | $9.6B | $9.4B | $10.7B | $11.1B | |
| Total Equity | $2.1B | $2.6B | $3B | $4.2B | $4.5B | |
| Total Debt | $2.1B | $2.2B | $2.2B | $2.2B | $2.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $773M | $1.7B | $644M | -$690M | -$224M | |
| Cash From Investing | -$790M | -$744M | -$464M | -$25M | $19M | |
| Cash From Financing | -$441M | -$58M | -$347M | $3M | $67M | |
| Free Cash Flow | $682M | $1.6B | $544M | -$685M | -$235M | |
MOH
Sector
Market Cap
$18.3B
$37M
Price % of 52-Week High
80.52%
43.14%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.03%
1-Year Price Total Return
-19.82%
-43.58%
Beta (5-Year)
0.701
0.746
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$318.44
200-day SMA
Buy
Level
$313.46
Bollinger Bands (100)
Buy
Level
287.34 - 317.94
Chaikin Money Flow
Buy
Level
77.5M
20-day SMA
Buy
Level
$316.34
Relative Strength Index (RSI14)
Buy
Level
62.25
ADX Line
Buy
Level
17.25
Williams %R
Sell
Level
-6.4857
50-day SMA
Buy
Level
$303.05
MACD (12, 26)
Buy
Level
6.26
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Neutral
Level
122M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.5804)
Buy
CA Score
(Annual)
Level (0.1014)
Sell
Beneish M-Score
(Annual)
Level (-2.1169)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.086)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). It has four segments: Medicaid, Medicare, Marketplace and Others. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. The Other segment, which is insignificant to its consolidated results of operations, includes long-term services and supports consultative services in Wisconsin. It generates majority revenue from Medicaid segment.
Stock Forecast FAQ
In the current month, MOH has received 6 Buy ratings 7 Hold ratings, and 0 Sell ratings. The MOH average analyst price target in the past 3 months is $338.38.
-
Where Will Molina Healthcare Stock Be In 1 Year?
According to analysts, the consensus estimate is that Molina Healthcare share price will rise to $338.38 per share over the next 12 months.
-
What Do Analysts Say About Molina Healthcare?
Analysts are divided on their view about Molina Healthcare share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Molina Healthcare is a Sell and believe this share price will drop from its current level to $279.00.
-
What Is Molina Healthcare's Price Target?
The price target for Molina Healthcare over the next 1-year time period is forecast to be $338.38 according to 13 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is MOH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Molina Healthcare is a Hold. 7 of 13 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MOH?
You can purchase shares of Molina Healthcare via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Molina Healthcare shares.
-
What Is The Molina Healthcare Share Price Today?
Molina Healthcare was last trading at $330.05 per share. This represents the most recent stock quote for Molina Healthcare. Yesterday, Molina Healthcare closed at $329.39 per share.
-
How To Buy Molina Healthcare Stock Online?
In order to purchase Molina Healthcare stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 15.53% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 3.89% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 1.54% over the past day.
